Oregon Public Employees Retirement Fund grew its stake in Edwards Lifesciences Corporation (NYSE:EW) by 7.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 52,856 shares of the medical research company’s stock after purchasing an additional 3,493 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Edwards Lifesciences Corporation were worth $5,778,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Edwards Lifesciences Corporation by 2.0% in the 2nd quarter. Vanguard Group Inc. now owns 20,748,569 shares of the medical research company’s stock valued at $2,453,311,000 after purchasing an additional 406,901 shares in the last quarter. BlackRock Inc. raised its stake in shares of Edwards Lifesciences Corporation by 0.8% in the 2nd quarter. BlackRock Inc. now owns 14,109,514 shares of the medical research company’s stock valued at $1,668,309,000 after purchasing an additional 105,819 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Edwards Lifesciences Corporation by 161.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,304,536 shares of the medical research company’s stock valued at $627,207,000 after purchasing an additional 3,277,726 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Edwards Lifesciences Corporation by 7.0% in the 3rd quarter. American Century Companies Inc. now owns 2,224,010 shares of the medical research company’s stock valued at $243,107,000 after purchasing an additional 144,701 shares in the last quarter. Finally, Wells Fargo & Company MN raised its stake in shares of Edwards Lifesciences Corporation by 13.3% in the 2nd quarter. Wells Fargo & Company MN now owns 2,119,260 shares of the medical research company’s stock valued at $250,581,000 after purchasing an additional 248,293 shares in the last quarter. Institutional investors and hedge funds own 82.32% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Edwards Lifesciences Corporation (EW) Stake Raised by Oregon Public Employees Retirement Fund” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/10/edwards-lifesciences-corporation-ew-stake-raised-by-oregon-public-employees-retirement-fund-2.html.

A number of brokerages have recently issued reports on EW. Canaccord Genuity restated a “buy” rating and issued a $155.00 target price on shares of Edwards Lifesciences Corporation in a research note on Sunday, October 8th. Cowen and Company restated a “buy” rating and issued a $135.00 target price on shares of Edwards Lifesciences Corporation in a research note on Thursday, October 12th. Barclays PLC cut their target price on shares of Edwards Lifesciences Corporation from $120.00 to $118.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 25th. BidaskClub lowered shares of Edwards Lifesciences Corporation from a “buy” rating to a “hold” rating in a research note on Friday, August 25th. Finally, Zacks Investment Research lowered shares of Edwards Lifesciences Corporation from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 17th. Seven analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the stock. Edwards Lifesciences Corporation presently has a consensus rating of “Buy” and a consensus price target of $125.17.

In other news, VP Donald E. Bobo, Jr. sold 5,300 shares of the stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $112.15, for a total value of $594,395.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Larry L. Wood sold 18,960 shares of the firm’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $108.54, for a total transaction of $2,057,918.40. The disclosure for this sale can be found here. Insiders sold 138,580 shares of company stock valued at $15,039,844 over the last quarter. Insiders own 2.13% of the company’s stock.

Edwards Lifesciences Corporation (NYSE:EW) opened at $104.78 on Friday. The company has a quick ratio of 2.76, a current ratio of 3.49 and a debt-to-equity ratio of 0.33. The stock has a market cap of $22,270.88, a P/E ratio of 29.15, a PEG ratio of 1.89 and a beta of 0.46. Edwards Lifesciences Corporation has a 1-year low of $81.12 and a 1-year high of $121.45.

Edwards Lifesciences Corporation (NYSE:EW) last posted its quarterly earnings data on Tuesday, October 24th. The medical research company reported $0.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.02). The company had revenue of $821.50 million during the quarter, compared to the consensus estimate of $833.85 million. Edwards Lifesciences Corporation had a net margin of 22.47% and a return on equity of 27.22%. The company’s revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the business earned $0.68 earnings per share. analysts anticipate that Edwards Lifesciences Corporation will post 3.75 EPS for the current fiscal year.

Edwards Lifesciences Corporation Profile

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient’s diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World.

Want to see what other hedge funds are holding EW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Edwards Lifesciences Corporation (NYSE:EW).

Institutional Ownership by Quarter for Edwards Lifesciences Corporation (NYSE:EW)

Receive News & Stock Ratings for Edwards Lifesciences Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences Corporation and related stocks with our FREE daily email newsletter.